Kauker M L, Baer P G, Nasjletti A
Kidney Int. 1987 May;31(5):1092-6. doi: 10.1038/ki.1987.113.
We contrasted the renal effects of vasopressin in Brattleboro rats with and without pretreatment with aprotinin (20,000 KIU kg-1). In both treatment groups, vasopressin injected at 3 mU kg-1 sec caused in conscious rats elevation of urine osmolality and reduction of urine flow and urinary excretion of total solutes. However, these effects of vasopressin were significantly greater in aprotinin pretreated rats than in rats without aprotinin treatment. In ketamine-pentobarbital-anesthetized rats without aprotinin pretreatment, vasopressin infused at 2 mU kg-1 hr-1 elevated urinary kinin excretion but did not affect urine flow rate or osmolality; in contrast, in aprotinin-pretreated rats, the same dose of vasopressin did not increase urinary kinins but caused elevation of urinary osmolality and reduction of urine flow, solute excretion, and glomerular filtration rate. Aprotinin pretreatment in anesthetized rats also blunted the rise in kinin excretion elicited by vasopressin at a higher dosage, 5 mU kg-1 hr-1, but did not potentiate the vasopressin-induced antidiuresis. We conclude that aprotinin facilitates the expression of the antidiuretic effect of vasopressin at a low, but not at a high dosage. This effect of aprotinin may be a consequence of: renal kallikrein inhibition which prevents augmentation of renal kinins in response to increased vasopressin levels, or other unrecognized properties of aprotinin.
我们对比了在有和没有用抑肽酶(20,000 KIU kg-1)预处理的Brattleboro大鼠中血管加压素对肾脏的影响。在两个治疗组中,以3 mU kg-1 sec注射血管加压素均使清醒大鼠的尿渗透压升高,尿流量及总溶质的尿排泄减少。然而,血管加压素的这些作用在经抑肽酶预处理的大鼠中比未用抑肽酶治疗的大鼠显著更强。在未用抑肽酶预处理的氯胺酮-戊巴比妥麻醉大鼠中,以2 mU kg-1 hr-1输注血管加压素可使尿激肽排泄增加,但不影响尿流率或渗透压;相反,在经抑肽酶预处理的大鼠中,相同剂量的血管加压素并未增加尿激肽,但导致尿渗透压升高,尿流量、溶质排泄及肾小球滤过率降低。在麻醉大鼠中进行抑肽酶预处理也减弱了血管加压素在较高剂量5 mU kg-1 hr-1时引起的激肽排泄增加,但并未增强血管加压素诱导的抗利尿作用。我们得出结论,抑肽酶在低剂量而非高剂量时促进血管加压素抗利尿作用的表达。抑肽酶的这种作用可能是由于:抑制肾激肽释放酶,从而防止因血管加压素水平升高而导致肾激肽增加,或者是抑肽酶的其他未被认识的特性。